HDAC4 and osteoporosis: For example, screening downstream relevant pathways regulated by HDAC4 and investigating their potential for targeted therapies in bone development or bone diseases and developing interventions targeting HDAC4 to promote bone formation or attenuate bone loss in osteoporosis.